Table 1.
Study Name | Geographic Location | Study Period | Controls | Cases | Serous | Mucinous | Endometrioid | Clear cell |
---|---|---|---|---|---|---|---|---|
Disease of the Ovary and their Evaluation Study 12 | Washington | 2002–2009 | 495 | 285 | 171 | 7 | 41 | 25 |
Hawaii Ovarian Cancer Study 11 | Hawaii | 1994–2007 | 106 | 90 | 45 | 7 | 10 | 6 |
Hormones and Ovarian Cancer Prediction 14a | Western Pennsylvania, Northeast Ohio, Western New York | 2003–2008 | 594 | 253 | 167 | 8 | 26 | 17 |
New England Case-Control Study of Ovarian Cancer 13 | New Hampshire, Eastern Massachusetts | 1999–2008 | 362 | 286 | 183 | 16 | 47 | 16 |
University of Southern California, Study of Lifestyle and Women’s Health 9a | Los Angeles, California | 1993–2005 | 738 | 595 | 354 | 37 | 56 | 41 |
Total: | 2295 | 1509 | 920 b | 75 b | 180 b | 105 b |
Some of the study’s primary data were included in the Collaborative Group’s analysis 8.
Sum of numbers do not equal total number of cases because some cases were not classified as one of the four histotypes considered.